Skip to main content
Erschienen in: Reactions Weekly 1/2020

01.08.2020 | Case report

Multipe drugs

Acquired drug resistance: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Trujillo JA, et al. Secondary resistance to immunotherapy associated with beta-catenin pathway activation or PTEN loss in metastatic melanoma. Journal for ImmunoTherapy of Cancer 7: 295, No. 1, 8 Nov 2019. Available from: URL: http://doi.org/10.1186/s40425-019-0780-0 Trujillo JA, et al. Secondary resistance to immunotherapy associated with beta-catenin pathway activation or PTEN loss in metastatic melanoma. Journal for ImmunoTherapy of Cancer 7: 295, No. 1, 8 Nov 2019. Available from: URL: http://​doi.​org/​10.​1186/​s40425-019-0780-0
Metadaten
Titel
Multipe drugs
Acquired drug resistance: 2 case reports
Publikationsdatum
01.08.2020
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-82177-6

Weitere Artikel der Ausgabe 1/2020

Reactions Weekly 1/2020 Zur Ausgabe

Case report

Pemetrexed